Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-20
pubmed:abstractText
Sprouty protein is a novel feedback regulator involved in downstream inactivation of several growth factor receptor pathways. Sprouty2 (Spry2) protein was shown to be downregulated in human cancers. High levels of microRNA-21 (miRNA-21) expression have been associated with poor survival and poor response to adjuvant chemotherapy in cancer patients. But the effect of Spry2 in human colon cancer remained unknown. Paired tumor and normal mucosa samples from patients were examined for their expression of Spry2 mRNA and miRNA-21 by real-time quantitative RT-PCR analysis. Our results show that Spry2 was downregulated in human colon cancer, and its expression levels were lower in advanced-stage tumors than in early-stage tumors. There was a negative correlation between the expression levels of Spry2 and miRNA-21. Furthermore, overexpression of Spry2 suppressed the growth and migration of colon cancer cells with a concomitant increase in PTEN expression and reduction of Akt and MAPK phosphorylation. Spry2 inhibited the growth and tumorigenesis of colon cancer cells in vivo. Conclusively, we show for the first time that Spry2 expression is downregulated and miRNA-21 is upregulated in the clinical samples of colon cancer, which correlates with clinical stage of disease. Thus, Spry2 functions as a tumor suppressor in colon cancer.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1555-8576
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
111-21
pubmed:meshHeading
pubmed-meshheading:21099344-Animals, pubmed-meshheading:21099344-Cell Growth Processes, pubmed-meshheading:21099344-Colonic Neoplasms, pubmed-meshheading:21099344-Down-Regulation, pubmed-meshheading:21099344-Female, pubmed-meshheading:21099344-Gene Expression Regulation, Neoplastic, pubmed-meshheading:21099344-Gene Knockdown Techniques, pubmed-meshheading:21099344-Genes, Tumor Suppressor, pubmed-meshheading:21099344-HCT116 Cells, pubmed-meshheading:21099344-HT29 Cells, pubmed-meshheading:21099344-Humans, pubmed-meshheading:21099344-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:21099344-Mice, pubmed-meshheading:21099344-Mice, Inbred BALB C, pubmed-meshheading:21099344-Mice, Nude, pubmed-meshheading:21099344-MicroRNAs, pubmed-meshheading:21099344-Mitogen-Activated Protein Kinases, pubmed-meshheading:21099344-Neoplasm Staging, pubmed-meshheading:21099344-PTEN Phosphohydrolase, pubmed-meshheading:21099344-Phosphorylation, pubmed-meshheading:21099344-Proto-Oncogene Proteins c-akt, pubmed-meshheading:21099344-RNA, Messenger, pubmed-meshheading:21099344-RNA, Small Interfering, pubmed-meshheading:21099344-Transfection, pubmed-meshheading:21099344-Transplantation, Heterologous
pubmed:year
2011
pubmed:articleTitle
Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease.
pubmed:affiliation
National Cheng Kung University, Tainan, Taiwan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't